Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals

NCT03790085 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

2700

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Major Depressive Disorder
Anxiety Disorders

Interventions

DRUG: Risperidone
DRUG: Olanzapine
DRUG: Aripiprazole

Sponsor

Tianjin Medical University General Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]